...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice
【24h】

IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice

机译:IL-33介导抗原诱导的小鼠皮肤和关节痛觉过敏

获取原文
获取原文并翻译 | 示例
           

摘要

IL-33, a new member of the IL-1 family, signals through its receptor ST2 and induces T helper 2 (Th2) cytokine synthesis and mediates inflammatory response. We have investigated the role of IL-33 in antigen-induced hypernociception. Recombinant IL-33 induced cutaneous and articular mechanical hypernociception in a time- and dose-dependent manner. The hypernociception was inhibited by soluble (s) ST2 (a decoy receptor of IL-33), IL-1 receptor antagonist (IL-1ra), bosentan [a dual endothelin (ET)_A/ET_B receptor antagonist], clazosentan (an ET_A receptor antagonist), or indomethacin (a cyclo-oxygenase inhibitor). IL-33 induced hypernociception in IL-18~(-/-) mice but not in TNFR1~(-/-) or IFNγ~(-/-) mice. The IL-33-induced hypernociception was not affected by blocking IL-15 or sympathetic amines (guanethidine). Furthermore, methylated BSA (mBSA)-induced cutaneous and articular mechanical hypernociception depended on TNFR1 and IFNy and was blocked by sST2, IL-1ra, bosentan, clazosentan, and indomethacin. mBSA also induced significant IL-33 and ST2 mRNA expression. Importantly, we showed that mBSA induced hypernociception via the IL-33→TNFα → IL-1β →IFNγ→ ET-1 → PGE_2 signaling cascade. These results therefore demonstrate that IL-33 is a key mediator of immune inflammatory hypernociception normally associated with a Th1 type of response, revealing a hitherto unrecognized function of IL-33 in a key immune pharmacological pathway that may be amenable to therapeutic intervention.
机译:IL-1 33家族的新成员IL-33通过其受体ST2发出信号,并诱导T辅助2(Th2)细胞因子合成并介导炎症反应。我们已经研究了IL-33在抗原诱导的痛觉过敏中的作用。重组IL-33以时间和剂量依赖性方式诱导皮肤和关节机械性神经痛。高伤害感受受到可溶性ST2(IL-33的诱饵受体),IL-1受体拮抗剂(IL-1ra),波生坦[双重内皮素(ET)_A / ET_B受体拮抗剂],克拉佐坦(ET_A)的抑制受体拮抗剂)或消炎痛(环加氧酶抑制剂)。 IL-33在IL-18〜(-/-)小鼠中引起高伤害感受,但在TNFR1〜(-/-)或IFNγ〜(-/-)小鼠中不诱发。 IL-33诱导的痛觉感受不受阻滞IL-15或交感胺(胍乙啶)的影响。此外,甲基化的牛血清白蛋白(mBSA)引起的皮肤和关节机械性痛觉过敏依赖于TNFR1和IFNγ,并被sST2,IL-1ra,波生坦,克拉佐森和吲哚美辛阻断。 mBSA还诱导了重要的IL-33和ST2 mRNA表达。重要的是,我们显示mBSA通过IL-33→TNFα→IL-1β→IFNγ→ET-1→PGE_2信号级联反应诱导了神经痛。因此,这些结果表明,IL-33是通常与Th1型反应相关的免疫炎性痛觉超敏反应的关键介体,揭示了迄今为止关键的免疫药理途径中IL-33尚未被认识的功能,该途径可能适合治疗干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号